Drug intelligence / Profile preview

NVP-1203-R2

Development stage: Unknown
Lead developer: NVP Healthcare
Modality: Small Molecules
Administration: Oral

Overview

NVP-1203-R2 is a small molecule drug developed by NVP Healthcare Co., Ltd. It is involved in a Phase I clinical trial to evaluate its pharmacokinetic interaction and safety compared to NVP-1203-R1 in healthy adult subjects. The specific therapeutic area or mechanism of action for NVP-1203-R2 is not detailed in the available information.

Targets

COXCaV (Voltage-gated calcium channel protein complex)

Beyond the preview

Go deeper on NVP-1203-R2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NVP-1203-R2.

Explore the full profile